Atlas Trials

An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)

Clinical trial NCT00606541 · TERMINATED

Trial details

NCT number
NCT00606541
Sponsor
Duke University
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Social Anxiety Disorder
Start date
2008-01-01
Primary completion
2011-12-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.